Free Trial

Trupanion (NASDAQ:TRUP) Price Target Raised to $67.00

Trupanion logo with Finance background

Key Points

  • Analysts at Piper Sandler have raised their price target for Trupanion from $62.00 to $67.00, indicating a potential upside of 37.44% from its previous close.
  • Lake Street Capital reduced their price target for Trupanion to $60.00, maintaining a "buy" rating, while the average target price among analysts is currently $54.80.
  • Trupanion reported a quarterly earnings per share of $0.22, surpassing estimates, and its revenue increased by 12.3% year-over-year, indicating financial growth despite a negative margin.
  • Need Better Tools to Track Trupanion? Try 5 Weeks of MarketBeat All Access for $5. Start Portfolio Tracking Now.

Trupanion (NASDAQ:TRUP - Get Free Report) had its price target increased by stock analysts at Piper Sandler from $62.00 to $67.00 in a research note issued on Friday,Benzinga reports. The firm currently has an "overweight" rating on the financial services provider's stock. Piper Sandler's price target points to a potential upside of 37.44% from the stock's previous close.

Separately, Lake Street Capital lowered their price objective on shares of Trupanion from $65.00 to $60.00 and set a "buy" rating for the company in a research report on Friday, May 2nd. Two investment analysts have rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the company currently has an average rating of "Moderate Buy" and an average target price of $54.80.

Get Our Latest Stock Analysis on Trupanion

Trupanion Trading Up 0.2%

TRUP opened at $48.75 on Friday. Trupanion has a twelve month low of $31.00 and a twelve month high of $57.90. The firm has a market cap of $2.09 billion, a PE ratio of -487.45 and a beta of 1.78. The company has a debt-to-equity ratio of 0.38, a quick ratio of 1.70 and a current ratio of 1.70. The firm's fifty day moving average is $51.08 and its two-hundred day moving average is $44.01.

Trupanion (NASDAQ:TRUP - Get Free Report) last released its quarterly earnings data on Thursday, August 7th. The financial services provider reported $0.22 earnings per share for the quarter, beating the consensus estimate of ($0.03) by $0.25. Trupanion had a negative return on equity of 1.33% and a negative net margin of 0.32%. The business had revenue of $353.56 million for the quarter, compared to analysts' expectations of $346.73 million. During the same quarter in the previous year, the business posted ($0.14) EPS. Trupanion's revenue for the quarter was up 12.3% on a year-over-year basis. Equities research analysts anticipate that Trupanion will post 0.13 EPS for the current year.

Insider Buying and Selling at Trupanion

In other news, CFO Fawwad Qureshi sold 2,534 shares of the stock in a transaction dated Thursday, May 29th. The shares were sold at an average price of $48.31, for a total transaction of $122,417.54. Following the completion of the transaction, the chief financial officer directly owned 3,545 shares in the company, valued at $171,258.95. This represents a 41.68% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO John R. Gallagher sold 4,000 shares of Trupanion stock in a transaction dated Thursday, May 29th. The shares were sold at an average price of $47.90, for a total value of $191,600.00. Following the completion of the sale, the chief operating officer directly owned 26,966 shares in the company, valued at approximately $1,291,671.40. This represents a 12.92% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 11,562 shares of company stock worth $544,870. Insiders own 5.42% of the company's stock.

Institutional Investors Weigh In On Trupanion

Large investors have recently made changes to their positions in the stock. Balyasny Asset Management L.P. lifted its stake in Trupanion by 368.2% in the fourth quarter. Balyasny Asset Management L.P. now owns 841,254 shares of the financial services provider's stock valued at $40,548,000 after acquiring an additional 661,559 shares during the last quarter. Wellington Management Group LLP lifted its stake in Trupanion by 13.2% in the 1st quarter. Wellington Management Group LLP now owns 2,491,227 shares of the financial services provider's stock valued at $92,848,000 after purchasing an additional 290,788 shares during the last quarter. Jacobs Levy Equity Management Inc. boosted its stake in shares of Trupanion by 2,029.0% during the 1st quarter. Jacobs Levy Equity Management Inc. now owns 303,550 shares of the financial services provider's stock worth $11,313,000 after acquiring an additional 289,292 shares during the period. BNP Paribas Financial Markets increased its holdings in shares of Trupanion by 170.7% in the fourth quarter. BNP Paribas Financial Markets now owns 337,093 shares of the financial services provider's stock valued at $16,248,000 after purchasing an additional 212,545 shares during the last quarter. Finally, Hosking Partners LLP raised its position in shares of Trupanion by 86.9% in the first quarter. Hosking Partners LLP now owns 397,656 shares of the financial services provider's stock valued at $14,821,000 after purchasing an additional 184,936 shares during the period.

Trupanion Company Profile

(Get Free Report)

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.

Read More

Analyst Recommendations for Trupanion (NASDAQ:TRUP)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Trupanion Right Now?

Before you consider Trupanion, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Trupanion wasn't on the list.

While Trupanion currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

3 Buy-the-Dip Stocks Poised to Rebound Soon
Quantum Boom: 3 Strong Picks with Lower Risk
3 Overlooked AI Stocks That Chipmakers Can’t Live Without

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines